Thel, M C <br/><br/>
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.  [electronic resource] 

 -  The American journal of cardiology  Feb 2000 
 - 427-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9149(99)00767-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angina, Unstable--mortality<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Coronary Thrombosis--mortality<br/>Electrocardiography<br/>Eptifibatide<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--etiology<br/>Peptides--administration & dosage<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Prospective Studies<br/>Risk Factors<br/>Secondary Prevention<br/>Survival Rate<br/>Thrombolytic Therapy<br/>Time Factors<br/>Treatment Outcome<br/>United States--epidemiology